Page last updated: 2024-08-24

phosphoramidic acid and Hemorrhagic Fever, Ebola

phosphoramidic acid has been researched along with Hemorrhagic Fever, Ebola in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bannister, R; Barauskas, O; Bavari, S; Carra, E; Chun, K; Cihlar, T; Clarke, MO; Doerffler, E; Feng, JY; Hui, HC; Jordan, R; Knox, J; Lee, G; Lee, WA; Lew, W; Lo, MK; Mackman, RL; Neville, S; Perron, M; Perry, J; Ray, AS; Rheingold, AL; Ross, B; Siegel, D; Soloveva, V; Stray, KM; Strickley, R; Swaminathan, S; Wang, Q; Warren, TK; Wolfe, L; Xu, Y; Zhang, L1

Other Studies

1 other study(ies) available for phosphoramidic acid and Hemorrhagic Fever, Ebola

ArticleYear
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses.
    Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Cell Line; Drug Discovery; Hemorrhagic Fever, Ebola; Humans; Microbial Sensitivity Tests; Phosphoric Acids; Prodrugs; Ribonucleotides; Structure-Activity Relationship; Virus Diseases

2017